Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig disease, involves progressive loss of motor neurons (a type of nerve cell controlling muscle movements) in the brain and spinal cord. ALS is a progressive, disabling, and ultimately fatal disease of unknown cause. Walking, speaking, swallowing, breathing, and other basic functions become impaired with time. About 30 000 Americans currently have ALS. The yearly incidence rate is 1 to 2 new cases per 100 000 individuals. The disease is commonly discovered during middle age and affects more men than women. The July 11, 2007, issue of JAMA includes an article discussing the diagnosis of ALS and recommendations for palliative (supportive) care.
It is estimated that more than 50% of motor neurons are lost before symptoms such as muscle weakness become apparent.
Gradual muscle weakness and wasting in arms and legs
Muscle fasciculations (twitches visible in muscles)
Difficulty with swallowing, speaking, and breathing
Muscle stiffness, bodily pains, and cramps, especially at night
Respiratory failure is the usual cause of death in ALS. Other causes include pneumonia. In most cases, death occurs within 3 to 6 years after symptoms begin, although some individuals with ALS live for many years, even decades.
Grahic Jump Location
Diagnosis is based on a careful medical history, physical examination, and laboratory tests. Electromyograms (EMGs)—nerve conduction studies that evaluate nerve and muscle function—are the key tests. Other tests may include blood tests and neuroimaging studies such as CT or MRI scans of the brain and spinal cord. Molecular testing, cerebrospinal fluid tests, or muscle biopsy may be necessary.
Physical, occupational, and speech therapies can assist in daily functioning.
Riluzole is the only medication approved for the treatment of ALS. It may prolong survival by a few months.
Other medications may relieve symptoms such as muscle pain, cramping, drooling, spasms, and fatigue.
Appropriate exercises to help maintain mobility, strength, and energy
Changes in diet to minimize episodes of choking and ensure adequate nutrition
Effective use of assistive devices and braces such as neck collar, foot brace, cane, walker, or wheelchair
Ramps, handrails, raised toilet seat, shower seat
Erasable writing tablets or voice amplifiers and computers to help communication
A noninvasive ventilator (breathing machine) may be important to support breathing
The progressive, disabling nature of ALS and the fact that there is no cure make it a difficult disease to manage. In addition to medical care, patients need emotional support from family, friends, doctors, and caregivers.
Muscular Dystrophy Association ALS Division (MDA)http://www.als.mdausa.org
Amyotrophic Lateral Sclerosis Association (ALSA)http://www.alsa.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish.
Sources: Muscular Dystrophy Association, Amyotrophic Lateral Sclerosis Association
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.
TOPIC: NEUROLOGICAL DISEASE
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Care at the Close of Life EDUCATION GUIDESPalliative Care for Patients with Amyotrophic Lateral Sclerosis
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.